75 related articles for article (PubMed ID: 23197684)
21. SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma.
Fan Z; Duan J; Luo P; Shao L; Chen Q; Tan X; Zhang L; Xu X
Cell Death Dis; 2022 Apr; 13(4):330. PubMed ID: 35411037
[TBL] [Abstract][Full Text] [Related]
22. Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning.
Luo J; Chen Y; Yang Y; Zhang K; Liu Y; Zhao H; Dong L; Xu J; Li Y; Wei W
Front Med (Lausanne); 2021; 8():777142. PubMed ID: 35127747
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Lamas NJ; Martel A; Nahon-Estève S; Goffinet S; Macocco A; Bertolotto C; Lassalle S; Hofman P
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008260
[TBL] [Abstract][Full Text] [Related]
24. Incidence and mortality of uveal melanoma in Australia (1982-2014).
Beasley AB; Preen DB; McLenachan S; Gray ES; Chen FK
Br J Ophthalmol; 2023 Mar; 107(3):406-411. PubMed ID: 34880052
[TBL] [Abstract][Full Text] [Related]
25. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients.
Guleser UY; Sarici AM; Ucar D; Gonen B; Sengul Samanci N; Özgüroğlu M
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1337-1343. PubMed ID: 34735632
[TBL] [Abstract][Full Text] [Related]
26. Estrogen Receptor Is Expressed in Uveal Melanoma: A Potential Target for Therapy.
Schoenfield L; Janse S; Kline D; Aronow ME; Singh AD; Craven C; Abdel-Rahman M; Cebulla CM
Ocul Oncol Pathol; 2021 Sep; 7(4):303-310. PubMed ID: 34604204
[TBL] [Abstract][Full Text] [Related]
27. Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma.
Miller M; Schoenfield L; Abdel-Rahman M; Cebulla CM
Ocul Oncol Pathol; 2021 Sep; 7(4):239-250. PubMed ID: 34604195
[TBL] [Abstract][Full Text] [Related]
28. Primary Sites of Uveal Melanoma Associated with Distinct Survival Outcomes and Clinicopathological Features: A SEER Population-Based Study of 4359 Cases.
Liang X; Rong Y; Wang J; Zhang H
Int J Gen Med; 2021; 14():5221-5232. PubMed ID: 34512005
[TBL] [Abstract][Full Text] [Related]
29. A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.
Tang Z; Cai K
Anal Cell Pathol (Amst); 2021; 2021():6693219. PubMed ID: 34434692
[TBL] [Abstract][Full Text] [Related]
30. Uveal Melanoma in Asians: A Review.
Manchegowda P; Singh AD; Shields C; Kaliki S; Shah P; Gopal L; Rishi P
Ocul Oncol Pathol; 2021 Jun; 7(3):159-167. PubMed ID: 34307326
[TBL] [Abstract][Full Text] [Related]
31. Impact of Therapy & Age in Choroidal Cancers: A Retrospective Cohort Analysis of 7722 Patients from a US National Database.
Hussain Z; Khan J; Ali S
Clin Ophthalmol; 2021; 15():1763-1774. PubMed ID: 33953535
[TBL] [Abstract][Full Text] [Related]
32. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
33. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
[TBL] [Abstract][Full Text] [Related]
34. Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage.
Vardanyan S; Brosig A; Merz H; Ranjbar M; Kakkassery V; Grisanti S; Tura A
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751097
[TBL] [Abstract][Full Text] [Related]
35. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
37. No Gender Differences in Long-Term Survival after Brachytherapy of 1,541 Patients with Uveal Melanoma.
Stålhammar G; See TR; Filì M; Seregard S
Ocul Oncol Pathol; 2019 Oct; 5(6):432-439. PubMed ID: 31768367
[TBL] [Abstract][Full Text] [Related]
38. Uveal Melanoma in Ireland.
Baily C; O'Neill V; Dunne M; Cunningham M; Gullo G; Kennedy S; Walsh PM; Deady S; Horgan N
Ocul Oncol Pathol; 2019 Apr; 5(3):195-204. PubMed ID: 31049328
[TBL] [Abstract][Full Text] [Related]
39. Expression of EZH2 in uveal melanomas patients and associations with prognosis.
Cheng Y; Li Y; Huang X; Wei W; Qu Y
Oncotarget; 2017 Sep; 8(44):76423-76431. PubMed ID: 29100322
[TBL] [Abstract][Full Text] [Related]
40. PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.
Vaquero-Garcia J; Lalonde E; Ewens KG; Ebrahimzadeh J; Richard-Yutz J; Shields CL; Barrera A; Green CJ; Barash Y; Ganguly A
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4096-4105. PubMed ID: 28828481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
